Vinorelbine en es it fr

Vinorelbine Brand names, Vinorelbine Analogs

Vinorelbine Brand Names Mixture

  • No information avaliable

Vinorelbine Chemical_Formula


Vinorelbine RX_link

Vinorelbine fda sheet

Vinorelbine msds (material safety sheet)

Vinorelbine Synthesis Reference

No information avaliable

Vinorelbine Molecular Weight

778.932 g/mol

Vinorelbine Melting Point

No information avaliable

Vinorelbine H2O Solubility

No information avaliable

Vinorelbine State


Vinorelbine LogP


Vinorelbine Dosage Forms


Vinorelbine Indication

For the treatment of non-small-cell lung carcinoma

Vinorelbine Pharmacology

Vinorelbine is a vinca alkaloid antineoplastic agent used as a treatment for various cancers including breast cancer, Hodgkin's disease, Kaposi's sarcoma, and testicular cancer. The vinca alkaloids are structurally similar compounds comprised of 2 multiringed units, vindoline and catharanthine. The vinca alkaloids have become clinically useful since the discovery of their antitumour properties in 1959. Initially, extracts of the periwinkle plant (Catharanthus roseus) were investigated because of putative hypoglycemic properties, but were noted to cause marrow suppression in rats and antileukemic effects in vitro. Vinorelbine binds to the microtubular proteins of the mitotic spindle, leading to crystallization of the microtubule and mitotic arrest or cell death. Vinorelbine has some immunosuppressant effect. The vinca alkaloids are considered to be cell cycle phase-specific.

Vinorelbine Absorption

No information avaliable

Vinorelbine side effects and Toxicity

No information avaliable

Vinorelbine Patient Information

No information avaliable

Vinorelbine Organisms Affected

Humans and other mammals